WuXi Biologics ISIN: KYG970081173 Forum: Aktien User: Summer.76

https://m.jrj.com.cn/madapter/hk/2021/12/31085634090855.shtml ...So far this year (since the passing of the ordinary resolution), the cumulative number of securities repurchased is 32.155 million shares, accounting for 0.76% of the number of shares issued at the time of passing the ordinary resolution.

Guten Rutsch 🍾🍀🙋🏼‍♀️

...und heute erneut: WuXi Biologics (02269) repurchased 4.489 million shares for HK$400 million on December 30 https://m.jrj.com.cn/madapter/hk/2021/12/30212734088520.shtml

Und es ging weiter damit: http://www.aastocks.com/en/stocks/news/aafn-con/NOW.1152327/company-news WUXI BIO (02269 HK) Buys back 3.448M Shrs for $300M

Aktienrückkäufe sind immer gut😉 nur leider im Kurs nicht zu sehen.

WUXI BIO Splashes Almost $200M to Buy back 2.252M Shrs http://aastocks.com/en/stocks/analysis/stock-aafn-con/02269/NOW.1152150/all

aktuell WuXi Biologics and ImmuneOncia Sign MOU for Development and Manufacturing of Anti-PD-L1/CD47 Bispecific Antibody https://www.prnewswire.com/news-releases/wuxi-biologics-and-immuneoncia-sign-mou-for-development-and-manufacturing-of-anti-pd-l1cd47-bispecific-antibody-301450916.html ...and ImmuneOncia Therapeutics, Inc., a clinical-stage, immuno-oncology company in South Korea, today announced that a Memorandum of Understanding (MOU) was signed to form a strategic partnership in the development and manufacturing of IOH-001, ImmuneOncia's therapeutic bispecific antibody targeting PD-L1 and CD47.   ...

vom 24.12. First Shanghai: Maintain WuXi Biologics (02269) "Buy" rating target price of 108.7 Hong Kong dollars https://m.jrj.com.cn/madapter/hk/2021/12/24103534056842.shtml

Hong Kong stocks move | WuXi AppTec (02359) fell 8%, leading the decline in CXO sector demand side concerns as one of the main reasons for the sell-off https://m.jrj.com.cn/madapter/hk/2021/12/20150934034504.shtml

https://finance.yahoo.com/news/sell-rumor-fails-china-biotech-061006902.html Sell the Rumor Fails in China Biotech Stocks as They Roar Back

Are WuXi Biologics (Cayman) Inc.'s (HKG:2269) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness? https://simplywall-st.cdn.ampproject.org/v/s/simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2269/wuxi-biologics-cayman-shares/news/are-wuxi-biologics-cayman-incs-hkg2269-fundamentals-good-eno-1/amp?amp_js_v=a6&amp_gsa=1&usqp=mq331AQKKAFQArABIIACAw%3D%3D#aoh=16397189517819&referrer=https%3A%2F%2Fwww.google.com&amp_tf=Von%20%251%24s&ampshare=https%3A%2F%2Fsimplywall.st%2Fstocks%2Fhk%2Fpharmaceuticals-biotech%2Fhkg-2269%2Fwuxi-biologics-cayman-shares%2Fnews%2Fare-wuxi-biologics-cayman-incs-hkg2269-fundamentals-good-eno-1

https://finance.sina.cn/hkstock/sckxjfx/2021-12-17/detail-ikyakumx4670485.d.html?from=wap ...On the news, WuXi Biologics announced that on December 16, 2021, the company will issue approximately 453,000 shares under the share option plan and repurchase 7,943,500 shares at a cost of approximately HK$700 million, with a price of HK$86.7-89.4 per share. Hong Kong dollar. ...

Ich hab heute auch leicht nachgekauft

Ist ja eine offizielle Liste. Aber momentan werden die Nerven hier ziemlich auf die Probe gestellt 🤪

Danke für die Infos 🙏 Sollte sich dies bewahrheitet, wäre es zumindest ein kleines Zeichen, dass noch etwas Verstand und logisches Denken bei den regierenden vorhanden ist...